Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
Video shows moment small plane lands on Pennsylvania highway
Dramatic video shows moment small plane lands on Pennsylvania...
Is AI Killing Web Traffic? How AI Overviews Impact Organic Website Traffic
Every few years, marketing headlines announce the demise of...
McDonald’s CEO Responds to the Viral Big Arch Backlash
Watch as McDonald’s chief takes his first on-camera bite...